baber/WOPTO huggingface dataset:
Patent AU-2004249692-B2 (AU)
Title: Mold table sensing and automation system
Inventor: ANDERSEN MICHAEL K
IPC: B22D11/18
Filed: 2004-06-09
Granted: 2010-09-30
Abstract: A molten metal sensing and automation system for use with or in a metal casting mold. Aspects of the invention include a molten metal automation system which may include a bleedout detection system which provides an automated response, and an automated system for the preparation of the starting blocks for casting.
Patent AU-2004257448-B2 (AU)
Title: Conjugated biological molecules and their preparation
Inventor: SHAUNAK SUNIL
IPC: A61K47/48
Filed: 2004-07-12
Granted: 2010-09-23
Abstract: A process for the preparation of a compound of the general formula:   
in which one of X and X' represents polyethylene glycol, and the other represents a hydrogen atom; 
each Q independently represents a linking group; 
W represents a keto group CO, an ester group -O-CO- or a sulphone group -SO 2 -, or a group obtained by reduction of such a group; or, if X' represents polyethylene glycol, X-Q-W-together represent a cyano group;  
Z represents a protein which is linked to A and B via two thiol groups which have been derived from a disulphide bridge in the protein; A is a C 1-5  alkylene or alkenylene chain; and 
B is a bond or a C 1-4  alkylene or alkenylene chain; which comprises reducing a disulfide bridge in a protein, and reacting the resultant product in an aqueous reaction medium with either (i) a compound of the general formula   
in which X, X', Q, A, B and L have the meanings given above, W' represents a keto or aldehyde group CO, an ester group 
-O-CO- or a sulphone group -SO 2 -, and each L independently represents a leaving group; 
or (ii) a compound of the general formula   
in which X, X', Q, W', A and L have the meanings given for the general formula II, and m represents an integer 1 to 4.  Also claimed is novel intermediate ±-methoxy-É-4-[2,2-bis[(p-tolylsulfonyl)methyl]-acetyl]benzamide poly(ethylene glycol).
Patent AU-2005273646-B2 (AU)
Title: Container closure assembly with internal neck thread
Inventor: MILNER KING ROGER
IPC: B65D51/28
Filed: 2005-08-22
Granted: 2011-09-15
Abstract: A container neck and closure assembly, wherein the container neck (10) comprises a first screw thread (14) on an internal surface thereof and the closure (12) comprises a cylindrical plug (32) for insertion into the container neck, said plug having a second screw thread (36, 37) on an outer surface thereof for engagement with the first screw thread to secure and resecure the closure on the neck.
Patent AU-2005295640-B2 (AU)
Title: Multi-domain amphipathic helical peptides and methods of their use
Inventor: DEMOSKY STEPHEN J
IPC: C07K14/775
Filed: 2005-10-14
Granted: 2011-07-28
Abstract: Disclosed herein are peptides or peptide analogs with multiple amphipathic α-helical domains that promote lipid efflux from cells via an ABCAl-dependent pathway. Also provided herein are methods of using multi-domain amphipathic α-helical peptides or peptide analogs to treat or inhibit dyslipidemic disorders. Methods for identifying non-cytotoxic peptides that promote ABCA1-dependent lipid efflux from cells are also disclosed herein.
Patent AU-2005338260-B2 (AU)
Title: High Capacity Scheduler
Inventor: THOMASSON RIKARD
IPC: G06F9/46
Filed: 2005-11-18
Granted: 2010-12-23
Abstract: A first interface for receiving downlink data packets from a core network, a second interface for transmitting data packets to user entities, a processor comprising a scheduler, a first memory partition comprising and parameter data pertaining to a first subset of allocated priority queues, a second memory partition comprising parameter data pertaining to a second subset of allocated priority queues, is provided. The processor is transferring parameter data between the first and second memory partitions, and vice versa, whereby parameter data for priority queues having no data packets in corresponding buffers is prioritized for being transferred to the first memory partition, parameter data for priority queues having data packets in corresponding buffers is prioritized for being transferred to the second memory partition, the processor performing scheduling based on a selection of priority queues whose parameter data is residing in the second memory partition.
Patent AU-2006213925-B2 (AU)
Title: A sports racquet with string port holes and a method for fabricating such a sports racquet
Inventor: ROBERTO GAZZARA
IPC: A63B49/02
Filed: 2006-09-12
Granted: 2011-11-17
Abstract: A sports racquet having a plurality of string port holes and conventional string holes is formed of a single tube of prepreg material. When molded, mold elements press opposed portions of the prepreg tube into contact with one another, and shape the adjoining prepreg material into a string port hole blanks. The portion of the pressed-together material which initially blocks the string port hole is removed after molding so that the string port holes extend through the frame. Alternatively, the mold elements cause the prepreg tube to follow a serpentine shape, thereby defining string port holes which are open alternately along the top and bottom surface of the frame. A pair of cover rings may be secured to the top and bottom racquet surfaces to cover the open sides of the string port holes. 2b 2bF 32a 34 FIG. 2a 32a 32a 38 34 FIG. 2b 367 3732a 38 34 32b FIG. 2c 3632b C) Coo co CD w Co co co CO, (0 ci
Patent AU-2006227942-B2 (AU)
Title: Pupilometer for pupil center drift and pupil size measurements at differing viewing distances
Inventor: CHERNYAK DIMITRI
IPC: A61B3/10
Filed: 2006-02-22
Granted: 2012-06-21
Abstract: The present invention generally provides improved devices, systems, and methods for measuring characteristics of at least one eye, and particularly for measuring the physiological changes in eyes under different viewing conditions. An exemplary embodiment provides a pupilometer which measures any changes in location of a pupil center with changes in viewing distances. As the eye often moves significantly during viewing, the pupil center location will often be measured relative to a convenient reference of the eye such as an outer iris boundary. Pupil size may also be recorded, and the measurements from both eyes of a patient may be taken simultaneously. Exemplary embodiments may be configured so as to allow the vergence angle between the eyes to vary with differing viewing distances, regardless of whether one or both eyes are being measured.
Patent AU-2006230478-B2 (AU)
Title: Treatment of eye disorders with sirtuin modulators
Inventor: MICHELLE DIPP
IPC: A61K31/353
Filed: 2006-03-30
Granted: 2011-12-22
Abstract: Sirtuin modulators, particularly sirtuin activators, are useful in treating vision impairment. In general, the sirtuin modulators inhibit the progression of vision impairment resulting from various eye disorders. The invention also includes pharmaceutically acceptable formulations of sirtuin modulators, particular ophthalmically acceptable formulations.
Patent AU-2006230657-B2 (AU)
Title: A support device for use with a dock leveller
Inventor: TIEMAN DALE
IPC: B65G69/22
Filed: 2006-10-17
Granted: 2012-09-20
Abstract: A support device 10 for use with a ramp 20 pivotally attached to a support structure 30 and having means for pivoting the ramp 20 between 5 lowered and raised positions relative to the support structure 30, the support device 10 including a supporting member 50 and means for actuating the supporting member 50 between a stowed position associated with when the ramp 20 is in the lowered position and a supporting position in which the supporting member 50 supports the ramp 20 in the raised position. W:sharon\ anieAComplete Applicaions\Tieman Industries (Final Version) 17oct06d0oC 00o C).
Patent AU-2006256518-B2 (AU)
Title: Method and composition for treating inflammatory disorders
Inventor: PERESWETOFF-MORATH LENA
IPC: A61K31/56
Filed: 2006-06-08
Granted: 2012-03-15
Abstract: There is provided homogeneous pharmaceutical compositions for the treatment of inflammatory disorders comprising an antiinflammatory and/or antihistaminic active ingredient, a polar lipid liposome and a pharmaceutically-acceptable aqueous carrier.
Patent AU-2006306593-B2 (AU)
Title: Method of operating a plurality of clean room
Inventor: SPENGLER CHARLES W
IPC: F24F11/00
Filed: 2006-10-12
Granted: 2012-04-19
Abstract: A method of operating a plurality of clean room in a compound within a common enclosure and supplying each room with filtered air by a blower-filter unit by arranging the clean rooms and the blowers connected thereto in two parallel spaced rows with a corridor therebetween, and permitting filtered air to escape the clean rooms from beneath the walls of the clean rooms. Continuous operation of the blowers produces a bubble-like volume of air surrounding the blowers which consists primarily of clean, recirculated air escaping from the clean rooms. By arranging the clean rooms and blowers so that the clean air bubble produced by each blower overlaps the bubbles produced by at least two other blowers, the entire compound can be contained in a highly purified atmosphere consisting primarily of recirculated filtered air. A portion of the air from one or more clean rooms may be discharged in an upward direction through ;an opening in its top wall.
Patent AU-2007201338-B2 (AU)
Title: Endoscopic instrument with secondary vacuum source
Inventor: STOKES MICHAEL J
IPC: A61B17/062
Filed: 2007-03-28
Granted: 2012-06-21
Abstract: An endoscopic instrument to be used with an endoscope. The instrument includes an elongated tube having a distal end and a proximal end, an end effector attached to the distal end of the elongated tube, and a handle attached to the proximal end. The handle includes a mechanism for attaching the instrument to a first vacuum source. The handle further includes a second vacuum source integral with the handle for amplifying the first vacuum source, whereby the first and second vacuum sources combine to operate the end effector.
Patent AU-2007222080-B2 (AU)
Title: Cancer treatment combining lymphodepleting agent with CTLs and cytokines
Inventor: PETERSON PER A
IPC: A01N63/00
Filed: 2007-02-23
Granted: 2012-08-16
Abstract: In a cancer treatment combining cell therapy with chemotherapy, autologous CD8 T cells are obtained from a patient, activated ex vivo by contacting them with xenogenic antigen presenting cells loaded with selected peptide antigen, thereby generating antigen- specific activated cytotoxic T lymphocytes. Such activated CTLs are administered to the patient in conjunction with a lymphodepletion and CTL maintenance regimen comprising a non-myeloblative but lymphdepleting agent, such as cladribine or denileukin diftitox, and interleukin-2 and interferon-α-2b stimulatory cytokines.
Patent AU-2007253771-B2 (AU)
Title: Devices and methods for fluorescent inspection and/or removal of material in a sample
Inventor: JONES RONALD M
IPC: G01N33/574
Filed: 2007-05-17
Granted: 2013-09-05
Abstract: An apparatus is provided that includes a light emitting component, a light detecting component, a lock in amplifier, a frequency generator that is operatively linked to the lock in amplifier and the light emitting component, a speaker capable of emitting an audio signal wherein the output audio signal varies depending on the detected fluorescence in the sample, and a visible output of relative fluorescent intensity where the visible output varies depending on the detected fluorescence in the sample. The apparatus may also include a laser that is operatively coupled to the lock in amplifier through a control switch, and focusing lens or an additional type of filter such as an interference filter, a short pass filter, a notch filter, a long pass filter or an infrared filter. The apparatus may be used to identify and/or to remove fluorescent or non fluorescent material from a sample. Associated methods are also disclosed.
Patent AU-2007275586-B2 (AU)
Title: Conductor casing installation by anchor handling/tug/supply vessel
Inventor: VAN LUIPEN PIETER
IPC: E21B19/16
Filed: 2007-02-08
Granted: 2012-04-05
Abstract: An anchor handling/tug/supply (AHTS ) vessel is employed to engage conductor casings with the seafloor. The conductor casings initially penetrate the seafloor to a first depth under their own weight. The conductor casings may optimally be further engaged with the seafloor to a second depth by the application of suction to the interiors thereof or by the use of a drop hammer. The conductor casings are driven to grade by a hydraulic pile driving hammer deployed from the deck of the AHTS vessel the previously deployed conductor casings to grade before being recovered to the desk of the AHTS vessels.
Patent AU-2007297395-B2 (AU)
Title: Gravel pack apparatus that includes a swellable element
Inventor: TIBBLES RAYMOND J
IPC: E21B43/26
Filed: 2007-09-13
Granted: 2013-01-10
Abstract: A gravel pack apparatus for use in a wellbore includes a screen assembly to filter particulates, at least one shunt conduit to carry gravel slurry, and a swellable element around a portion of the at least one shunt conduit. The swellable element swells in response to an input stimulus and expands radially outwardly to seal against the wellbore.
Patent AU-2007312906-B2 (AU)
Title: Processes for preparing fertilized egg components
Inventor: BAIN JERALD
IPC: A61K35/57
Filed: 2007-10-12
Granted: 2013-06-27
Abstract: The invention relates to processes for preparing fertilized egg components using freeze-drying and/or extraction methods.
Patent AU-2008202967-B2 (AU)
Title: Abuse-Resistant Controlled-Release Opioid Dosage Form
Inventor: CARUSO FRANK S
IPC: A61K9/20
Filed: 2008-07-03
Granted: 2011-09-22
Abstract: Abuse-Resistant Controlled-Release Opioid Dosage Form Abuse-resistant, controlled release opioid tablets in combination containing an opioid antagonist such as naloxone at a level above that needed to suppress the euphoric effect of the opioid, if the combination were crushed to break the controlled release properties causing the opioid and opioid antagonist to be released as an immediate release product as a single dose. The controlled release nature of the tablet prevents the accumulation of orally effective amounts of opioid antagonist when taken normally. The opioid antagonist is contained in a controlled-release matrix and released, over time, with the opioid.
Patent AU-2008255907-B2 (AU)
Title: Apparatus for Coating Lenses
Inventor: TAKAHASHI NAOTO
IPC: B05C11/00
Filed: 2008-05-21
Granted: 2012-12-06
Abstract: Provided is a coating device for a lens (10), in which at least one of a lens measuring unit (3), a primer coating unit (5), a photochromic coating unit (7) and a UV irradiation unit (8) supports the central bottom portion of the lens, and in which support shafts (57, 78, 85 and 97) perform any operations. Transfer means (45, 63 and 68) have adsorption portions for supporting the central bottom portions of the lenses. Lens mounting portions (58, 72, 74, 81, 88 and 115) are disposed around the support shafts, and have pins for supporting the lens bottom face other than the regions, in which the support shafts and the adsorption portions support the lenses. At the transfer times of the lenses between the support shafts and the transfer means and between the transfer means and other transfer means, the lenses are tentatively placed on the lens mounting portions, and at least one of the lens mounting portions, the support shafts and the transfer means is vertically moved to support the lenses on the support shafts or the transfer means. With this constitution, the lenses can be transferred between the devices while being neither subjected to any moment nor distorted.
Patent AU-2008270207-B2 (AU)
Title: Method, apparatus and system for mobility management and efficient information retrieval in a communications network
Inventor: KLEFTER MARC
IPC: H04L29/12
Filed: 2008-07-04
Granted: 2014-01-16
Abstract: A method and apparatus of forming a generic overlay network for efficient information retrieval in a communications network, comprising receiving (204) in a domain router (103) a register request from a mobile communications apparatus (106), the register request including an identification of said mobile communications apparatus; looking-up (205)) an address to a next-hop router (104) associated with the identification; sending (206) the register request to the next-hop router (104); receiving (210) a reply from the next-hop router (104); and if the reply includes an address to a home router (104), sending (211) a reply to the mobile communications apparatus (106) including the address of the home router (104), said reply initiating the establishment of a connection between the mobile communications apparatus (106) and the home router (104).
Patent AU-2008308854-B2 (AU)
Title: Oral care implement having a head insert
Inventor: BRUCE RUSSELL
IPC: A46B9/04
Filed: 2008-10-01
Granted: 2011-10-20
Abstract: An oral care implement is provided with a head platform having a plurality of faces and an insert retention space formed therebetween. The oral care implement can have an insert disposed within the insert retention space. The oral care implement can further include a transparent or translucent support member on one of the faces and a reflective insert within the insert retention space. The oral care implement can include a plurality of support members on the plurality of faces from which cleaning elements extend. The oral care implement can further include a fluid-permeable and/ or air-permeable support member on one of the faces and an insert containing a fluid-permeable and/ or air-permeable agent. The oral care implement can be formed by affixing a first AFT-tufted carrier plate to a first face of the head platform and affixing a second AFT-tufted carrier plate to the second face of the head platform.
Patent AU-2008308859-B2 (AU)
Title: System and method for forming a stent of a desired length at an endoluminal site
Inventor: DUCHARME RICHARD W
IPC: A61F2/82
Filed: 2008-10-01
Granted: 2014-01-23
Abstract: Described herein are a system (100) and a method for forming a stent of a desired length endoluminally. The system includes an elongate stent body (105) and an outer sheath (110) overlying the stent body. An endoluminal cutting mechanism (115) is operatively connected to a drive cable (120) in communication with the outer sheath. The cutting mechanism is configured to cut the stent body in response to motion of the drive cable. The method of forming the stent of a desired length endoluminally includes directing a system including an elongate stent body and an outer sheath overlying the stent body into a body lumen, positioning the stent body at an endoluminal site, and severing the stent body to form a stent of a desired length at the endoluminal site. An undeployed portion of the stent body remains in the outer sheath for optional deployment in a subsequent severing operation.
Patent AU-2008344935-B2 (AU)
Title: Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants
Inventor: AYAL SHARON
IPC: C07K14/415
Filed: 2008-12-23
Granted: 2013-08-29
Abstract: Polynucleotides, polypeptides, plant cells expressing same and methods of using same for increasing abiotic stress tolerance water use efficiency (WUE), fertilizer use efficiency (FUE), biomass, vigor and/or yield of a plant. The method is effected by expressing within the plant an exogenous polynucleotide encoding a polypeptide comprising an amino acid sequence at least 80 % homologous to the amino acid sequence selected from the group consisting of SEQ ID NOs:33, 34, 30, 27-29, 31, 32, 35-52, 1401-1403, 1405-1435, 1437-1494, 1496-1542, 1544-1553, 1555-1559, 1561-1827, 1829-1866, 1868-2450, 2453-2458, 2460-2463, 2465-2481, 2483, 2485-2746, 2765-2769, 3052-3065 and 3067-3259, thereby increasing the water use efficiency (WUE), the fertilizer use efficiency (FUE), the biomass, the vigor and/or the yield of the plant.
Patent AU-2009221728-B2 (AU)
Title: Polypeptides having beta-glucosidase activity and polynucleotides encoding same
Inventor: HARRIS PAUL
IPC: C12P19/02
Filed: 2009-03-06
Granted: 2014-07-10
Abstract: The present invention relates to isolated polypeptides having beta-glucosidase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Patent AU-2009246167-B2 (AU)
Title: Glucokinase activators
Inventor: WANG HAXIA
IPC: C07D417/14
Filed: 2009-05-15
Granted: 2013-08-22
Abstract: Compounds are provided for use with glucokinase that comprise the formula: ##STR## wherein the variables are as defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds; methods and intermediates useful for making the compounds; and methods of using said compounds.
Patent AU-2009248846-B2 (AU)
Title: Systems and methods for multiplexing multiple connections in mobile IP network
Inventor: WANG JUN
IPC: H04L12/70
Filed: 2009-05-22
Granted: 2014-04-17
Abstract: Disclosed are systems, methods and computer program products for facilitating multiplexing of simultaneous multiple connections between a mobile device and its IP mobility anchors, such as mobile IP home agents or proxy mobile IP local mobility anchors. An example method comprises assigning a unique IP mobility anchor identifier to each IP mobility anchor associated with the mobile device. The method further comprises negotiating an IP flow reservation for each IP mobility anchor identifier and signaling a request to associate each negotiated IP flow with an IP tunnel to a particular IP mobility anchor. The method further comprises sending packets through each negotiated IP flow and associated IP tunnel to each IP mobility anchor.
Patent AU-2009257739-B2 (AU)
Title: Devices, processes and methods for the production of lower alkyl esters
Inventor: ASHLEY TOM MICHAEL
IPC: C11C3/04
Filed: 2009-06-03
Granted: 2015-03-26
Abstract: Embodiments of a process for production of biodiesel from a transesterification reaction of alcohol and triglycerides in a multi-zone tubular reactor is disclosed. Alkyl esters and glycerin are formed from reactants in a reaction mixture as the reaction mixture flows through the zones. The zones include an entrance zone, an exit zone, and an intermediate zone between the entrance and exit zones. The zones are characterized by physical properties such as viscosity, density, composition, and flow regime. The entrance and intermediate zones include static mixers that perform structured mixing that increases the conversion and yield. The degree of mixing provided by the mixers is different in the zones to account for differences in physical properties. Additionally, the product stream from the reactor is passed through a coalescer to increase droplet size of a dispersed glycerin phase, facilitating both rapid separation of the glycerin phase from the biodiesel phase, and increased conversion and yield in a decanter.